<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39326796</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-6971</ISSN><JournalIssue CitedMedium="Internet"><Volume>179</Volume><PubDate><Year>2024</Year><Month>Sep</Month><Day>24</Day></PubDate></JournalIssue><Title>Fitoterapia</Title><ISOAbbreviation>Fitoterapia</ISOAbbreviation></Journal><ArticleTitle>Antileishmanial, antitrypanosomal and anti-coronavirus activities of benzophenanthridine alkaloids and other specialized metabolites isolated from the root bark of Zanthoxylum zanthoxyloides (Lam.) B.Zepernick &amp; Timler.</ArticleTitle><Pagination><StartPage>106232</StartPage><MedlinePgn>106232</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fitote.2024.106232</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0367-326X(24)00415-5</ELocationID><Abstract><AbstractText>Strong antileishmanial and antitrypanosomal activities were highlighted for the crude methanolic extract (IC<sub>50</sub> = 0.61 and 2.15 μg/mL, respectively) of Zanthoxylum zanthoxyloides (Lam.) B.Zepernick &amp; Timler root bark, as well as for its apolar partitions (cyclohexane: IC<sub>50</sub> = 0.66 and 5.17 μg/mL, respectively and dichloromethane: IC<sub>50</sub> = 0.07 and 0.22 μg/mL, respectively), with a good selectivity index (SI) towards WI-38 cells. In addition, cyclohexane and dichloromethane extracts exhibited a dose-dependent inhibition of human coronavirus HCoV-229E infection in hepatoma Huh-7 cells expressing or not the cellular protease TMPRSS2 (IC<sub>50</sub> values of 5.29 μg/mL and 4.87 μg/mL, respectively). Fractionation of these active extracts led to the isolation of a new racemic benzophenanthridine alkaloid named zanthoxyloithrine (1), together with 13 known compounds. Their structures were elucidated by spectroscopic techniques including IR, UV, HR-MS, 1D and 2D NMR and electronic circular dichroism. In parallel, HR-ESI-MS/MS based dereplication and molecular networking analysis were performed to identify unpurified compounds in cyclohexane and dichloromethane extracts. Zanthoxyloithrine (1) showed strong antileishmanial (IC<sub>50</sub> = 0.14 μM, SI = 52.0) and antitrypanosomal (IC<sub>50</sub> = 0.36 μM, SI = 20.8) activities. In addition, compound (1) demonstrated a high antiviral activity against HCoV-229E with IC<sub>50</sub> value of 6.70 μM in presence of TMPRRS2 and without significant toxicity on Huh-7 cells. Other purified benzo[c]phenanthridine alkaloids also showed anti-coronavirus and antiparasitic activities.</AbstractText><CopyrightInformation>Copyright © 2024 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ba</LastName><ForeName>Abda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Joint Research Unit 1158 BioEcoAgro, Univ. Lille, Junia, INRAE, Univ. Liège, UPJV, Univ. Artois, ULCO, F-59650 Villeneuve d'Ascq, France; Laboratoire de Chimie Organique et Thérapeutique, Faculté de Médecine, de Pharmacie et d'Odontologie de l'Université Cheikh Anta Diop de Dakar, BP 5005 Dakar-Fann, Sénégal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roumy</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Joint Research Unit 1158 BioEcoAgro, Univ. Lille, Junia, INRAE, Univ. Liège, UPJV, Univ. Artois, ULCO, F-59650 Villeneuve d'Ascq, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Ibrahim</LastName><ForeName>Malak</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Joint Research Unit 1158 BioEcoAgro, Univ. Lille, Junia, INRAE, Univ. Liège, UPJV, Univ. Artois, ULCO, F-59650 Villeneuve d'Ascq, France; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - Center for Infection and Immunity of Lille (CIIL), F-59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>Kristelle</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Pharmacognosy Research Group, Louvain Drug Research Institute, Université catholique de Louvain (UCLouvain), Avenue E. Mounier, 72, B B01.72.03-1200 Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hennebelle</LastName><ForeName>Thierry</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Joint Research Unit 1158 BioEcoAgro, Univ. Lille, Junia, INRAE, Univ. Liège, UPJV, Univ. Artois, ULCO, F-59650 Villeneuve d'Ascq, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samaillie</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Joint Research Unit 1158 BioEcoAgro, Univ. Lille, Junia, INRAE, Univ. Liège, UPJV, Univ. Artois, ULCO, F-59650 Villeneuve d'Ascq, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahpaz</LastName><ForeName>Sevser</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Joint Research Unit 1158 BioEcoAgro, Univ. Lille, Junia, INRAE, Univ. Liège, UPJV, Univ. Artois, ULCO, F-59650 Villeneuve d'Ascq, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beniddir</LastName><ForeName>Mehdi A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Equipe Chimie des Substances Naturelles, BioCIS, CNRS, Université Paris-Saclay, 17 Avenue des Sciences, 91400 Orsay, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hérent</LastName><ForeName>Marie-France</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Pharmacognosy Research Group, Louvain Drug Research Institute, Université catholique de Louvain (UCLouvain), Avenue E. Mounier, 72, B B01.72.03-1200 Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Séron</LastName><ForeName>Karin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - Center for Infection and Immunity of Lille (CIIL), F-59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leclercq</LastName><ForeName>Joëlle Quetin</ForeName><Initials>JQ</Initials><AffiliationInfo><Affiliation>Pharmacognosy Research Group, Louvain Drug Research Institute, Université catholique de Louvain (UCLouvain), Avenue E. Mounier, 72, B B01.72.03-1200 Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seck</LastName><ForeName>Matar</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratoire de Chimie Organique et Thérapeutique, Faculté de Médecine, de Pharmacie et d'Odontologie de l'Université Cheikh Anta Diop de Dakar, BP 5005 Dakar-Fann, Sénégal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivière</LastName><ForeName>Céline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Joint Research Unit 1158 BioEcoAgro, Univ. Lille, Junia, INRAE, Univ. Liège, UPJV, Univ. Artois, ULCO, F-59650 Villeneuve d'Ascq, France. Electronic address: celine.riviere@univ-lille.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Fitoterapia</MedlineTA><NlmUniqueID>16930290R</NlmUniqueID><ISSNLinking>0367-326X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anti-coronavirus</Keyword><Keyword MajorTopicYN="N">Antileishmanial</Keyword><Keyword MajorTopicYN="N">Antitrypanosomal</Keyword><Keyword MajorTopicYN="N">Benzophenanthridine alkaloids</Keyword><Keyword MajorTopicYN="N">Root bark</Keyword><Keyword MajorTopicYN="N">Zanthoxylum zanthoxyloides (Lam.) B.Zepernick &amp; Timler</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare no competing financial interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>19</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39326796</ArticleId><ArticleId IdType="doi">10.1016/j.fitote.2024.106232</ArticleId><ArticleId IdType="pii">S0367-326X(24)00415-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle>